Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography–tandem mass spectrometry

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 1998 · 5.5K citations · Full text

Medicine, Oncology, Preventive Medicine +15

Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

Bernard Fisher, James J. Dignam, John Bryant et al. · JNCI Journal of the National Cancer Institute · 1996 · 869 citations · Full text

Medicine, Gynecology, Oncology +16

Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine

Vered Stearns · JNCI Journal of the National Cancer Institute · 2003 · 849 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

J Cuzick, JF Forbes, Rob Edwards et al. · The Lancet · 2002 · 742 citations

Medicine, Preventive Medicine, Women's Health +1

Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6

Zeruesenay Desta, Bryan A. Ward, Nadia Soukhova et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 645 citations

Medicine, Biochemistry, Pharmacology +17